Research Progress on sdLDL-C and Type 2 Diabetes Combined with Hypertension Disease

临床观察表明，同时罹患2型糖尿病(T2DM)和高血压的个体普遍存在脂质代谢紊乱及血管内皮功能障碍，进一步可进展为动脉粥样硬化，小而密低密度脂蛋白(sdLDL-C)亚型在预测动脉粥样硬化进程和评估心血管事件风险方面具有重要的临床价值。因此，加强对这类患者sdLDL-C水平的监测，有助于更早实施干预措施，实现早期预防和治疗。Clinical observations indicate that lipid metabolism disorders and vascular endothelial dysfunction are prevalent in individuals with type 2 diabetes mellitus (T2DM) and hypertension, which can further progress to atherosclerosis. Small and dense low-density lipoprotein (sdLDL-C) subtypes have important clinical value in predicting the progression of atherosclerosis and assessing the risk of cardiovascular events. Therefore, strengthening the monitoring of sdLDL-C levels in such patients will help to implement interventions earlier and achieve early prevention and treatment.